Sökning: "Ki-67"
Visar resultat 6 - 10 av 82 avhandlingar innehållade ordet Ki-67.
6. Early Prostate Cancer, On prognostic markers and predictors of treatment outcome after radical prostatectomy
Sammanfattning : The incidence of prostate cancer (PC) has increased by 4.6% annually in Sweden during the past ten years. Today?s clinically used prognostic markers are not accurate enough to separate the potentially life-threatening tumours from the insignificant ones in 50-80% of newly diagnosed PCs. LÄS MER
7. Natural history and prognostic factors in localized prostate cancer
Sammanfattning : The natural history of localized prostate cancer is not fully understood. In most patients the tumor will never progress to a lethal disease, while a subset of patients will ultimately die of the disease. LÄS MER
8. Prognostic and predictive factors in laryngeal cancer treated with radiotherapy
Sammanfattning : Radiotherapy (RT) and surgery are the only two curative treatments for patients with laryngeal cancer (LC). RT has the advantage that it offers a possibility to preserve a functioning larynx and hence a functioning normal voice. The response of tumors to RT is heterogeneous, even within the same tumor stage. LÄS MER
9. Apoptosis, proliferation, and sex steroid receptors in endometrium and endometrial carcinoma
Sammanfattning : This thesis focuses on the involvement of apoptosis and proliferation in the mechanisms of menstruation and hormonal replacement therapy, HRT, as well as in the mechanisms of progesterone therapy in endometrial carcinoma. The aim of the first study was to investigate endometrium for 4 days before and for 2 days during menstruation. LÄS MER
10. Prognosis in carcinoma in situ of the breast
Sammanfattning : The incidence of breast cancer is rising steadily in Sweden and the proportion of carcinoma in situ (CIS) has increased appreciably, most likely due to mammography screening. The aim of this study was twofold: (1) to examine risk factors for subsequent invasive breast carcinoma and breast cancer death after primary ductal carcinoma in situ (DCIS) and (2) to study the biology in the progress between in situ and invasive carcinoma. LÄS MER